aid: selkirk-pharma
name: Selkirk Pharma
description: >-
  Selkirk Pharma, Inc. is a privately held U.S. contract development and manufacturing
  organization (CDMO) in Spokane, Washington, specializing in the aseptic fill/finish of sterile
  injectable drug products — vaccines, biologics and small molecules — for clinical and commercial
  supply. Founded in 2018, it operates a purpose-built aseptic campus at 9110 W Granite Avenue in
  the Pacific Northwest Technology Park, roughly half a mile from Spokane International Airport,
  running unidirectional personnel and material flow, single-use systems, SKAN isolator technology
  and Bausch+Strobel VarioSys dose-filling lines rated to about 3,600 vials per hour under EU GMP
  Annex 1. Services span aseptic filling, in-house analytical chemistry and microbiology, sterility
  testing, finished-product inspection, regulatory support and supply-chain services, plus a
  ClinFAST program that compresses fill/finish timelines for clinical-trial material. The build-out
  drew roughly $150M led by Spokane's Cowles Company with other Washington State investors, and
  Colleen Dixon was named chief executive in July 2024. Selkirk Pharma sells contract manufacturing
  capacity, not software: it operates no developer program, publishes no web API, SDK or
  machine-readable specification, and maintains no public source-code organization. (In this
  sector "API" ordinarily means active pharmaceutical ingredient; Selkirk fills and finishes drug
  product and publishes no web API.)
url: https://raw.githubusercontent.com/api-evangelist/selkirk-pharma/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment-pipeline
deliveryModel:
  model: unknown
  open_source: false
  commercial: false
  callable_host: false
  label: Delivery model not determined — needs a product licence on record
  confidence: low
  source:
  - none
  generated: '2026-08-28'
  method: derived
specificationVersion: '0.23'
created: '2026-08-26'
modified: '2026-08-26'
tags:
- Company
- Pharmaceuticals
- Contract Manufacturing
- CDMO
- Sterile Injectables
- Aseptic Fill Finish
- Biologics
- Life Sciences
- Clinical Trials
- Manufacturing
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/selkirk-pharma-domain-security.yml
- type: Website
  url: https://www.selkirkpharma.com/
- type: Careers
  url: https://www.selkirkpharma.com/careers
- type: Contact
  url: https://www.selkirkpharma.com/contact
- type: LinkedIn
  url: https://www.linkedin.com/company/selkirk-pharma
- type: SecondaryMarket
  url: https://forgeglobal.com/selkirk-pharma_stock/
x-enrichment:
  date: '2026-08-26'
  status: minimal
  artifacts_added: 2
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Selkirk Pharma is a sterile fill/finish CDMO in Spokane, Washington whose product is aseptic
    manufacturing capacity for injectable drugs, not software — there is no developer program, no
    API, no SDK on npm or PyPI, no GitHub organization, and every developer-shaped hostname
    (api./docs./developer./portal./app./login./status..selkirkpharma.com) is NXDOMAIN rather than a
    wildcard; the archived 2026-05-08 home page links 17 pages and all 17 are contract-manufacturing
    marketing. Separately worth recording for a re-run: the live Webflow edge refused the TLS
    handshake (alert 40) to curl, python ssl and openssl at both TLSv1.2 and TLSv1.3, so the site
    itself could only be read from the Wayback Machine — but that obstruction is not why this
    profile is thin.
  evidence:
  - url: https://www.selkirkpharma.com/
    status: 0
  - url: http://www.selkirkpharma.com/openapi.json
    status: 301
  - url: http://web.archive.org/web/20260508082831/https://www.selkirkpharma.com/
    status: 200
  - url: https://api.github.com/search/users?q=selkirk+pharma
    status: 200
  - url: https://pypi.org/pypi/selkirk-pharma/json
    status: 404
  checked: '2026-08-26'